Scott Curry to Clostridium Infections
This is a "connection" page, showing publications Scott Curry has written about Clostridium Infections.
Connection Strength
4.229
-
Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset, Clostridioides difficile infection (HO-CDI) to overestimate rates. Infect Control Hosp Epidemiol. 2020 04; 41(4):467-468.
Score: 0.665
-
To Lump or To Split: Does Strain Lineage for Clostridioides difficile Matter? J Clin Microbiol. 2019 05; 57(5).
Score: 0.632
-
Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection. Ann Pharmacother. 2019 04; 53(4):396-401.
Score: 0.613
-
Clostridium difficile. Clin Lab Med. 2017 06; 37(2):341-369.
Score: 0.546
-
Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania. J Clin Microbiol. 2014 Jul; 52(7):2406-9.
Score: 0.447
-
Therapeutic approaches for Clostridium difficile infections. Curr Protoc Microbiol. 2013 Oct 02; 30:9A.3.1-9A.3.9.
Score: 0.430
-
Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013 Oct; 57(8):1094-102.
Score: 0.424
-
Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB. J Clin Microbiol. 2011 Nov; 49(11):3788-93.
Score: 0.372
-
Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol. 2012 Dec; 50(12):4078-82.
Score: 0.100